BLRX had a strong rally today and it's just getting started.In the related idea my price target was $1.34.
Today's high was $1.78
Check out the weekly chart:
Photo Finish.
$1.34 was 1.618 extension level from Waves 1 & 2.
Since the price-action broke $1.34 we will have an extended 3rd wave.
I expect a very strong rally tomorrow, I will update in the morning before the open to confirm.
Target is hard to predict since its impossible to know what level extending waves will terminate.
I will keep a close eye on the price-action.
Will update.
-AB
註釋
As expected, a very strong rally today!註釋
註釋
We got a big runway...註釋
Reminder this is a WEEKLY chart...Meaning this move is far from over...
註釋
註釋
Buckle up!註釋
註釋
Target $2.24 (Sell Half)Trade Price: 1.049
註釋
註釋
註釋
Bull Flag註釋
BLRX will rally again tomorrow.註釋
註釋
BLRX is about to rally again...註釋
BLRX continued to consolidate today.Staying the course...
註釋
註釋
註釋
Near-Term Target: $2.13註釋
註釋
Primary Wave 1 Complete註釋
註釋
03:21 PM EDT, 10/22/2018 (MT Newswires) -- Oppenheimer has kept its outperform rating on BioLineRx (BLRX) with a price target of $3, betting on BL-8040's commercial opportunity as a stem cell mobilizer after top-line data from the COMBAT/KEYNOTE-202 trial of BL-8040 in combination with pembrolizumab in advanced pancreatic cancer showed modest response rate."Given the combination's favorable safety profile, BioLineRx and Merck (MRK) are testing a triplet combination including chemotherapy in an effort to increase response rate," analyst Mark Breidenbach said in a note.
"While we believe the triplet combination is worth testing, our valuation of BioLineRx still remains focused on BL-8040's commercial opportunity as a stem cell mobilizer."
註釋
註釋
註釋
Breakout Imminent註釋
免責聲明
這些資訊和出版物並非旨在提供，也不構成TradingView提供或認可的任何形式的財務、投資、交易或其他類型的建議或推薦。請閱讀使用條款以了解更多資訊。